Alzamend Neuro, Inc.
ALZN· Nasdaq
ALZNAlzamend Neuro, Inc.
Filed Mar 25, 2024 · 10-Q · 54 days after period end · 0001214659-24-005088
| Metric | Q3 2024 | Q3 2023 | Q3 2022 | Q3 2021 |
|---|---|---|---|---|
| Net Income | -$2.66M | -$5.43M | -$2.57M | -$1.12M |
| EPS Diluted | -$3.77 | -$0.83 | -$0.03 | -$0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Alzamend Neuro, Inc. · CIK 1677077 · Engraved from SEC EDGAR
ended Jan 31, 2024 · filed Mar 25, 2024 · 54 d after period end
